Navigation Links
SPX-106T Treatment Yields Significant Reductions in Serum VLDL and LDL Cholesterol in Mice
Date:9/8/2011

eclinical development of SPX-106T as a treatment for hypertriglyceridemia in one arm of a study designed to evaluate both D-tagatose alone and the combination.  The first studies designed specifically to test SPX-106T are nearing completion and results will be announced this fall. The Company plans to start an initial human efficacy study in the first quarter of 2012.  Rapid progression to the clinic is made possible by the experienced team in place at the Company.  

"Having just successfully completed two global clinical trials for a diabetes indication, Spherix has the personnel to design and execute new dyslipidemia trials much faster than other companies of a similar size," notes Dr. Claire Kruger, Chief Executive Officer of Spherix. "The preclinical pipeline of our Biospherics subsidiary can be advanced to the clinical stage rapidly because the Company is able to successfully execute multiple studies simultaneously."

About Spherix

Spherix Incorporated was launched in 1967 as a scientific research company under the name Biospherics Research.  The Company now leverages its scientific and technical expertise and experience through its two subsidiaries – Biospherics Incorporated and Spherix Consulting, Inc.  Biospherics is dedicated to developing and licensing/marketing proprietary therapeutic products for treatment of diabetes, metabolic syndrome and atherosclerosis.  Biospherics is actively seeking a pharmaceutical partner to continue the development of its Phase 3 compound for the treatment of diabetes, D-tagatose, while exploring new drugs and combinations for treatment of high triglycerides, a risk factor for atherosclerosis, myocardial infarction and stroke.  Spherix's Consulting subsidiary provides scientific and strategic support for suppliers, manufacturers, distributors and retailers of conventional foods, biotechnology-derived foods, medical foods, infant formulas, food ingredients, die
'/>"/>

SOURCE Spherix Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Angioslide Announces the European Launch of New 300 mm Long Device Allowing Treatment of Entire Superficial Femoral Artery(SFA) with One Device
2. Regulus Therapeutics to Present New Advancements in microRNA Therapeutics for Treatment of Metabolic Diseases and Cancer
3. ChromaDex®s Novel Ingredient pTeroPure® to be Studied as Potential Treatment for Fighting Skin Cancers
4. Nektar Initiates Second Phase 1 Clinical Study Evaluating NKTR-181, A Novel Opioid Molecule, for Treatment of Chronic Pain
5. Dominion Diagnostics Leads Fight Against Prescription Drug Abuse with Safe Use Treatment Monitoring Solution
6. ViroPharmas Buccolam® (Midazolam, Oromucosal Solution) Granted European Marketing Authorization for Treatment of Acute Seizures
7. Mesoblast Receives Clearance to Begin First European Trial of Allogeneic or Off-The-Shelf Stem Cell Treatment for Heart Attacks
8. VIVUS Announces FDA Acceptance of Avanafil New Drug Application for Treatment of Erectile Dysfunction
9. New Drug Approved for Treatment of Non Small Cell Lung Cancer in Specific Patient Population
10. Hatchtech Completes Treatment Phase of 2b Clinical Trial of New-Generation Head Lice Treatment Deovo™
11. Study Explores Utilization Trends for Prostate Cancer Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Schein, Inc. (NASDAQ: HSIC ), the world,s largest ... animal health and medical practitioners, announced today that the Company ... , September 4, 2014 – Baird 2014 Healthcare Conference in ... , September 8, 2014 – Morgan Stanley ... NY at 1:25 p.m. ET Henry Schein,s presentations ...
(Date:8/21/2014)... 2014  The board of directors of VirtualScopics, Inc. ... clinical trial imaging solutions, today announced that James ... effective immediately.  Mr. Groff has held the role of ... VirtualScopics in January 2006 as an accounting manager and ... "When the board of VirtualScopics asked Jim to assume ...
(Date:8/21/2014)...  SI-BONE, Inc. ( San Jose, California ... of the iFuse Implant System, ® a minimally ... sacroiliac (SI) joint, announced that Priority Health ( ... Fusion Medical Policy No. 91590-R4 providing positive coverage for ... that the fusion procedure, which employs the iFuse Implant ...
Breaking Medicine Technology:Henry Schein To Present At Two Investor Conferences In September 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 4SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 2SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 3
... New Mexico Software, Inc. (OTC ... IT services and solutions that enable improved and faster communication ... providing second opinion teleradiology interpretation for its customers. ... for patients and their families who want a second opinion ...
... 2011 Fujitsu , the market ... showcase its network scanning solutions for improved information sharing ... the Annual HIMSS Conference & Exhibition (Booth #5750) in ... network scanners has gained tremendous momentum by helping healthcare ...
Cached Medicine Technology:New Mexico Software Initiates Medical Second Opinion Service via Telemedicine for Remote Consultation Review 2New Mexico Software Initiates Medical Second Opinion Service via Telemedicine for Remote Consultation Review 3Fujitsu to Showcase New Document Imaging Technologies for Improved Information Sharing and Record Keeping at HIMSS 2011 2Fujitsu to Showcase New Document Imaging Technologies for Improved Information Sharing and Record Keeping at HIMSS 2011 3
(Date:8/21/2014)... One of the emerging trends that ... is an increasing adoption of non-invasive administration products. As ... patient through their convenient application, they find more preference ... medical device used for the administration of drugs for ... paranasal sinus such as allergic and non-allergic rhinitis and ...
(Date:8/21/2014)... According to a new market report ... Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 ... valued at USD 863.1 million in 2013 and is ... 2013 to 2019, to reach an estimated value of ... optics market is witnessing significant growth due to increased ...
(Date:8/21/2014)... It's a terrible thing when a young adult, full ... abuse issue. When that happens to a teenager in Pompano ... help from the qualified substance abuse therapists at a teen ... for those young adults living in Pompano Beach, FL who ... , Thankfully there is a new helpline operating for those ...
(Date:8/21/2014)... Tibet has long been a desired destination ... Prayers flags whip in the wind against the ... of chanting monks fill the otherwise silent temples. ... to Tibet is challenging due to high elevation and ... to be daunting for even the most experienced of ...
(Date:8/21/2014)... 21, 2014 Relias Learning, the leader ... and human services markets, announced the latest release of ... the Tin Can API. , “Supporting the Tin ... the most advanced mobile learning capabilities and the ability ... tools and techniques,” says Jim Triandiflou, CEO of Relias ...
Breaking Medicine News(10 mins):Health News:Intranasal Drug Delivery Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 2Health News:Intranasal Drug Delivery Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 3Health News:Intranasal Drug Delivery Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 4Health News:Intranasal Drug Delivery Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 5Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 2Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 3Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 4Health News:Young Adults in Pompano Beach, FL Are Finding Success With Innovative New Helpline 2Health News:Relias Learning Announces Support for Tin Can API 2
... , PENSACOLA, Fla., Sept. 24 In these ... in preventative healthcare. Better overall health means lower medical bills. ... percent of Americans took two weeks of vacation last year, and ... third in the past generation. The price Americans are paying, by ...
... Irvine, Calif. UC Irvine researchers have created ... of chemotherapeutic drugs to specific cells and organs. ... biophysics, and Richard Robertson, professor of anatomy & ... in diameter) of naturally-occurring lipid molecules, as "packages" ...
... , NEW YORK, Sept. 24 Reportlinker.com ... in its catalogue. , , ... Profiles, Implications for Immunoassays and Molecular Assays) ... , The outbreak of swine flu ...
... , IRVINE, Calif., Sept. 24 ... inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, ... for home care providers, jointly announce a preferred supplier agreement that ... Pulse Oximeters and sensors. Masimo,s solutions are proven to help ...
... ROCHESTER, Minn., Sept. 24 Mayo Clinic,s perspective about how to ... article in the New England Journal of Medicine , ... Oct. 1, 2009. , , (Logo: http://www.newscom.com/cgi-bin/prnh/20090105/MAYOLOGO ... other providers accountable for providing high-value health care, defined in terms of ...
... 2009) -- The Weill Cornell Institute of Geriatric ... has received the largest grant in its 20-year ... new $10 million, five-year "Center Grant" from the ... NewYork-Presbyterian/Weill Cornell investigators to advance their pioneering work ...
Cached Medicine News:Health News:Health-Related Tourism Catching On 2Health News:UCI researchers create new strategy for highly-selective chemotherapy delivery 2Health News:Reportlinker Adds H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays) Report 2Health News:Reportlinker Adds H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays) Report 3Health News:Reportlinker Adds H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays) Report 4Health News:The MED Group Signs Preferred Supplier Agreement for Masimo SET(R) Pulse Oximetry Solutions 2Health News:The MED Group Signs Preferred Supplier Agreement for Masimo SET(R) Pulse Oximetry Solutions 3Health News:The MED Group Signs Preferred Supplier Agreement for Masimo SET(R) Pulse Oximetry Solutions 4Health News:The MED Group Signs Preferred Supplier Agreement for Masimo SET(R) Pulse Oximetry Solutions 5Health News:Mayo Clinic Offers Perspective on Health Care Reform in New England Journal of Medicine 2Health News:Weill Cornell Institute for Geriatric Psychiatry awarded $10 million grant 2Health News:Weill Cornell Institute for Geriatric Psychiatry awarded $10 million grant 3Health News:Weill Cornell Institute for Geriatric Psychiatry awarded $10 million grant 4
... The total ergonomic solution and best ... Soft, feather touch action and ultra lightweight ... Stress-free tip ejection with long, lever tip ... identification , Accepts universal tips or for ...
... The Finnpipette BioControl multichannel ... features as the single ... handle fits allseven multichannel ... tip cone modules. Both ...
... Pipette is ideal for all liquid handling ... ergonomically-placed operating buttons, and various dispensing techniques ... diluting make this a lab favorite. It ... manual pipette without any adverse effects on ...
... Design for Unparalleled Comfort Pick one of ... balance. Notice the trigger and ejector positionsright where ... our pipettors are ergonomically designed to help avoid ... pipetting. Productivity In The Palm Of Your ...
Medicine Products: